1. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? 
Nadine M.P. Daan, M.D., Yvonne V. Louwers, M.D., Ph.D., Maria P.H. Koster, M.D., Ph.D., Marinus J.C. Eijkemans, Ph.D., Yolanda B. de Rijke, Ph.D., Eef W.G. Lentjes, Ph.D., Bart C.J.M. Fauser, M.D., Ph.D., Joop S.E. Laven, M.D., Ph.D. 
Fertility and Sterility 
Volume 102, Issue 5, Pages e3 (November 2014)
DOI: /j.fertnstert
Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Distribution of PCOS phenotypes in study population. AE = androgen excess; OD = ovulatory dysfunction; PCOM = polycystic ovarian morphology.
Fertility and Sterility  , e3DOI: ( /j.fertnstert )
Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

3. Supplemental Figure 1
Plot graphs showing the LH, FSH, E2, and T assay conversion formulas between centers.
Fertility and Sterility  , e3DOI: ( /j.fertnstert )
Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

4. Supplemental Figure 2
Plot graphs showing the DHEAS, A, SHBG, and insulin assay conversion formulas between centers.
Fertility and Sterility  , e3DOI: ( /j.fertnstert )
Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions